-
Recent Posts
Recent Comments
- MichaelOrdman on Fighting over Israeli engineers
- Elaine Morales on Fighting over Israeli engineers
- MichaelOrdman on Enriched seaweed can feed the world
- Professor Rajan Rajan on Enriched seaweed can feed the world
- MichaelOrdman on Fast glaucoma treatment in trials
Archives
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- July 2010
Categories
Meta
Search Results for: Brainstorm ALS
Positive results for Brainstorm’s ALS trial
As reported (here) previously, the stem cell treatment for ALS from Israel’s Brainstorm is doing well in trials. The latest Phase 2 trial of Brainstorm’s autologous bone-marrow derived MSC-NTF cells (Nurown) in 48 patients at 3 US sites was effective … Continue reading
Posted in Israel's Medical Achievements
Leave a comment
Video of Brainstorm’s ALS treatment
New ABC TV video of the 4-year human trials of the stem cell treatment from Israel’s Brainstorm on 26 ALS patients at Jerusalem’s Hadassah Medical Center. 90% have shown positive change. The patients’ own bone marrow stem cells are extracted, … Continue reading
Posted in Israel's Medical Achievements
Leave a comment
Another successful Brainstorm trial
A four-year study at Jerusalem’s Hadassah hospital of the stem cell treatment from Israel’s Brainstorm has been shown to inhibit the progression of the fatal neurological disease ALS (Lou Gehrig’s) in 87 percent of 26 patients. http://www.jpost.com/Business-and-Innovation/Health-and-Science/Optimistic-results-for-Phase-ALS-treatment-at-Jerusalem-hospital-441407
Posted in Israel's Medical Achievements
Leave a comment
ALS treatment trial shows success
Israel’s Brainstorm has announced positive final results from its phase 2a clinical trial of NurOwn cells in amyotrophic lateral sclerosis (ALS) patients used on 14 subjects at Hadassah Medical Center in Jerusalem. Nearly all subjects experienced clinical benefit. http://www.brainstorm-cell.com/index.php/news-events/331-january-5-2015
Posted in Israel's Medical Achievements
Leave a comment
ALS treatment is fast-tracked
The US FDA has designated NurOwn, developed by Israel’s Brainstorm, as a Fast Track product for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s Disease). http://jewishbusinessnews.com/2014/10/08/brainstorms-stem-cell-based-drug-nurown-gets-fda-fast-track-approval/
Posted in Israel's Medical Achievements
Leave a comment
ALS patients improve after stem cell treatment
Israel’s BrainStorm reported positive interim results of Phase IIa ALS trials of its “NurOwn” stem cell therapy. 71% of patients were in decline before treatment but after treatment 63% were either stabilized or had improved neurological function. http://www.brainstorm-cell.com/index.php/news-a-events/302-june-2-2014
Posted in Israel's Medical Achievements
Leave a comment
Israeli ALS treatment to be presented at Turkish conference
Professor Dimitrios Karussis, Principal Investigator of BrainStorm’s clinical trials of its ALS stem cell treatment at Jerusalem’s Hadassah Medical Center, will present at the Joint Congress of European Neurology, May 31-June 3 in Istanbul, Turkey. http://www.brainstorm-cell.com/index.php/news-a-events/299-may-19-2014
Posted in Israel's Medical Achievements
Leave a comment
Israeli ALS treatment cures Rabbi
(Thanks to NoCamels) ALS (Lou Gehrig’s) sufferer Rabbi Refael Shmulevitz had been given two to four years to live. He lost the ability to talk clearly and was confined to a wheelchair. Following Brainstorm‘s ‘NurOwn’ stem cell treatment he can … Continue reading
Posted in Israel's Medical Achievements
Leave a comment
Helping each other
This article describes many of the acts of kindness that Israelis perform to help other members of the Startup community. They include rent-free offices, networking, brainstorming, training, sharing data and referrals to investors. Although competition is fierce, Israeli entrepreneurs want … Continue reading
Posted in The Jewish State
Leave a comment
Pre-clinical success for Covid-19 ARDS treatment
Israel’s BrainStorm (reported here previously) reported promising results of pre-clinical trials for its Nurown treatment for Acute Respiratory Distress Syndrome (ARDS) brought about by Covid-19. The NurOwn cells reduced the cytokine storm and lung damage. https://ir.brainstorm-cell.com/2020-07-23-BrainStorm-Announces-Groundbreaking-Pre-Clinical-Study-of-NurOwn-R-derived-Exosome-Based-Treatment-for-COVID-19-ARDS
Posted in Israel's Medical Achievements
Leave a comment